Stilla Technologies’ €20 Million Series B Financing


Dechert advised Tuspark Capital Management, Illumina Ventures, Kurma Partners, Idinvest, LBO France, BNP Paribas Développement and Paris Saclay Seed Fund in connection with their Series B investment in Stilla Technologies.

Stilla Technologies raised a total amount of €20 million in in a Series B funding round that brought in a new investor, the Chinese group TUS-Holdings, alongside the participation of existing investors Illumina Ventures, Kurma Partners, LBO France, Paris Saclay Seed Funds, BNP Paribas Développement and Idinvest Partners.

Founded in 2013 at Ecole Polytechnique, Stilla Technologies is a company that develops, manufactures and sells equipment for the analysis of nucleic acids by digital PCR, for.

Dechert advised Stilla Technologies’ investors with a French team including Partner Anne-Charlotte Rivière (Picture), and Associate Claire Tanguy, on corporate/venture capital matters; and a US team including Partner Scott Warren and Patent Agent Kurtis Anderson on intellectual property matters.

Involved fees earner: Anne-Charlotte Rivière – Dechert; Claire Tanguy – Dechert; Scott Warren – Dechert;

Law Firms: Dechert;

Clients: BNP Paribas Développement; Idinvest Partners; Illumina Ventures; Kurma Partners; Lbo France; Paris Saclay Seed Fund; TUS-Holdings Co., Ltd.;